Cambridge Trust Co. Purchases 437 Shares of Danaher Co. (DHR)

Cambridge Trust Co. raised its position in Danaher Co. (NYSE:DHR) by 0.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 157,638 shares of the conglomerate’s stock after purchasing an additional 437 shares during the period. Cambridge Trust Co.’s holdings in Danaher were worth $16,256,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Ruggie Capital Group purchased a new position in shares of Danaher during the 4th quarter worth about $40,000. We Are One Seven LLC purchased a new position in shares of Danaher during the 4th quarter worth about $44,000. Legacy Financial Advisors Inc. lifted its holdings in shares of Danaher by 59.4% during the 4th quarter. Legacy Financial Advisors Inc. now owns 690 shares of the conglomerate’s stock worth $71,000 after acquiring an additional 257 shares during the period. NuWave Investment Management LLC lifted its holdings in shares of Danaher by 5,600.0% during the 4th quarter. NuWave Investment Management LLC now owns 798 shares of the conglomerate’s stock worth $82,000 after acquiring an additional 784 shares during the period. Finally, Parkside Financial Bank & Trust lifted its holdings in shares of Danaher by 76.7% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,016 shares of the conglomerate’s stock worth $105,000 after acquiring an additional 441 shares during the period. Institutional investors own 77.79% of the company’s stock.

NYSE DHR opened at $109.25 on Monday. Danaher Co. has a one year low of $91.84 and a one year high of $111.10. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.07 and a current ratio of 1.47. The company has a market capitalization of $76.57 billion, a P/E ratio of 24.17, a price-to-earnings-growth ratio of 2.01 and a beta of 0.99.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, January 29th. The conglomerate reported $1.28 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $0.01. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The firm had revenue of $5.40 billion for the quarter, compared to analyst estimates of $5.33 billion. During the same quarter last year, the firm posted $1.19 earnings per share. Danaher’s revenue for the quarter was up 6.2% compared to the same quarter last year. Equities research analysts predict that Danaher Co. will post 4.78 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, January 25th. Investors of record on Friday, December 28th were issued a $0.16 dividend. The ex-dividend date of this dividend was Thursday, December 27th. This represents a $0.64 annualized dividend and a yield of 0.59%. Danaher’s payout ratio is 14.16%.

Several brokerages have recently weighed in on DHR. Cowen reiterated a “buy” rating and set a $110.00 price objective on shares of Danaher in a report on Monday, January 7th. Needham & Company LLC assumed coverage on shares of Danaher in a report on Wednesday, January 2nd. They issued a “buy” rating and a $114.00 price target on the stock. Royal Bank of Canada restated a “hold” rating and issued a $102.00 price target on shares of Danaher in a report on Wednesday, December 19th. Finally, Robert W. Baird cut their price target on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a report on Friday, October 19th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $113.08.

TRADEMARK VIOLATION NOTICE: “Cambridge Trust Co. Purchases 437 Shares of Danaher Co. (DHR)” was first reported by WKRB News and is the property of of WKRB News. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.wkrb13.com/2019/02/11/cambridge-trust-co-purchases-437-shares-of-danaher-co-dhr.html.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

See Also: How to interpret the current ratio

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply